Prostate cancer (PCa) is the most common noncutaneous malignancy in men and is the second leading cause of cancer mortality in men in the United States. Current practice requires histopathological confirmation of cancer achieved through biopsy for diagnosis. The transrectal approach for prostate biopsy has been the standard for several decades. However, the risks and limitations of transrectal biopsies have led to a recent resurgence of transperineal prostatic biopsies. Recent studies have demonstrated the transperineal approach for prostate biopsies to be effective, associated with minimal complications and superior in several aspects to traditional transrectal biopsies. While sextant and extended sextant templates are widely accepted templates for transrectal biopsy, there are a diverse set of transperineal biopsy templates available for use, without consensus on the optimal sampling strategy. We aim to critically appraise the salient features of established transperineal biopsy templates.
Therapeutic advances in urology. 2022 Jun 26*** epublish ***
Abhinav Sidana, Fernando Blank, Hannah Wang, Nilesh Patil, Arvin K George, Hasan Abbas
Associate Professor of Surgery, Director of Urologic Oncology, Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA., Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Department of Urology, University of Michigan, Ann Arbor, MI, USA.